Prostate Cancer Diagnosis Made Easier

.

Prostate Cancer Diagnosis Made Easier

The team of physicians and engineers at the University of California-Los Angeles (UCLA) has now brought forward a new tool dubbed Artemis to diagnose prostate cancer.

Till now, doctors used an old technique to diagnose the disease by which it was quite difficult to test the cancer. They relied on biopsy which began 25 years ago and was not a good method to do the diagnosis.

The new technique used Magnetic Resonance Imaging (MRI) along with real time ultrasound system to fix the problem with the old technique. This new technology will help the doctors by letting them figuring out the cancer from high resolution 3-D images instead of inspecting the disease visually during biopsy.

The groundbreaking procedure will help to diagnose the prostate cancer earlier in men with serious cancers and those who have comparatively less serious disease can be helped to avoid unnecessary treatments. As expected by the health authorities, some 240,000 prostates cancers will be diagnosed in the United States this year; however, they affirmed that not every cancer is deadly.

"Artemis has delivered very dramatic results, and the rate of cancer detection in these targeted biopsies is very high. We're finding a lot of tumors", said Leonard Marks, MD, University of California-Los Angeles (UCLA) professor of urology and the Director of the UCLA Active Surveillance Program.


Latest News

DoubleLine Capital Sold Off All its European Equities Holdings following a Huge
Qualcomm Files Complaint against Meizu with Beijing Authorities over Intellectua
Barnes & Noble Broadening its Business Model Venturing into a Beer and Wine Stor
Will Result of the Brexit Vote Reflect in the U.S. Presidential Elections? A Que
Report Shows Large Number of Americans still Prefer Receiving Credit Card Statem
U.S. Big Banks Pass Annual Stress Test
Viacom’s Board will Remain as it is for the Time being, Judge Sets Hearing for J
Crude Stockpiles Drop in the U. S
A New Study Highlights that U. S. Expected to Spend $2.6 Trillion Less than Esti
SolarCity Shares Soar with Tesla's Bid for the Company
The Leave as well as Remain Camps Gathers Pace in Brexit
Oil’s Advance Halts as Market Awaits U.S Stock Pile Data and Brexit Poll